DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2024

Feb 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2024-02-10

Reporting Person: Spencer Ryan (Director, CEO and Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-10	Common Stock	M	20833	—	Acquired	212312	Direct
2024-02-12	Common Stock	F	11684	$12.82	Disposed	200628	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-10	Restricted Stock Unit	$	M	20833	Disposed		Common Stock (20833)	Direct

Footnotes

F1: Code M: Exercise or conversion of derivative security

F2: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.

F3: Code F: Payment of exercise price or tax liability by delivering or withholding securities

F4: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.